Designed for use with in vitro diagnostics assays for the quantitative determination of BNP in human serum and plasma. The Acusera BNP controls delivers an unbiased, independent assessment of analytical performance, helping to ensure accurate and reliable patient testing for BNP. Optimised for use on Beckman, Abbott and Siemens systems, these controls are also suitable for other platforms.
Features & Benefits
Liquid ready-to-use.
True third-party control.
Human serum based.
Optimised for use with Abbott, Beckman and Siemens. Also suitable for use with other platforms.